반응식
[C:1]([C:5]1[CH:13]=[C:12]2[C:8]([CH2:9][CH2:10][N:11]2[S:14]([C:17]2[CH:24]=[CH:23][C:20]([C:21]#[N:22])=[CH:19][CH:18]=2)(=[O:16])=[O:15])=[CH:7][C:6]=1[S:25]C#N)([CH3:4])([CH3:3])[CH3:2].S.[Na].[BH4-].[Na+].CO>CC(O)=O.O>[C:1]([C:5]1[CH:13]=[C:12]2[C:8]([CH2:9][CH2:10][N:11]2[S:14]([C:17]2[CH:18]=[CH:19][C:20]([C:21]#[N:22])=[CH:23][CH:24]=2)(=[O:15])=[O:16])=[CH:7][C:6]=1[SH:25])([CH3:4])([CH3:2])[CH3:3]참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
The title compound was prepared according to the General Method 14b using 4-(6-tert-butyl-5-thiocyanato-2,3-dihydro-indole-1-sulfonyl)-benzonitrile (prepared in Example MM; 6.0 g, 15 mmol), sodium hydrogen sulfide (2.53 g, 45.3 mmol), sodium borohydride (3.43 g, 90.7 mmol), MeOH (10 mL), water (5 mL), and AcOH (5 mL). The crude product was used further without any purification.
후처리
- customThe crude product was used further without any purification
출처 및 근거
- ORD 기록
- ord-672e2232cea54aab88fb8df72f87cd75
- 출처 데이터셋
- uspto-grants-2003_03
- 특허 번호
- US06528510B1
연결된 노트
불러오는 중…